Novartis, shadowed by data scandal, renews case for Zolgensma biopharmadive.com/news/novartis-… via BioPharma Dive

Interesting read on Mental Health apps. Mental health apps are scooping up your most sensitive data. Will you benefit? statnews.com/2019/09/20/men… via STAT

Biogen stops Phase 2 study in another hit to 'high-risk' pipeline biopharmadive.com/news/biogen-st… via BioPharma Dive

Disruptive or not? Uber Freight: The bright spot in Uber's portfolio? supplychaindive.com/news/uber-frei… via Supply Chain Dive

Is this about the best healthcare or best cost for employer? Amazon now pays for employees to get cancer care in California and expects to save on health-care costs, despite added travel expenses wsj.com/articles/amazo… via The Wall Street Journal

225,000 people getting vaccinated...I hopes this will help control the disease Congo to start using Johnson & Johnson Ebola vaccine in November reut.rs/2B9jz1W

Novartis' Zolgensma starts strong as about 100 infants are treated with gene therapy. #PIA is one of them. biopharmadive.com/news/novartis-… via BioPharma Dive

Major surprise, Biogen will ask FDA to approve Alzheimer's drug aducanumab. Is amyloid back in the running ? #Alzheimer biopharmadive.com/news/biogen-su…

I want to be a connector #connectsmarter ciodive.com/news/gartner-o…

Another step into Amazon's #virtualclinical. Amazon acquires digital health startup, #HealthNavigator healthcaredive.com/news/amazon-ac…?

Who will is still left? Amgen exits neuroscience R&D as pharma pulls back from field biopharmadive.com/news/amgen-exi… via BioPharma Dive

Had the pleasure to meet and learn from John Bates for the second time now thanks to JLABS in The Credibility, Resilience and Storytelling: A Training for Life Sciences Startups. More info - johnbatestraining.splashthat.com

Grateful for the opportunity to be part of the interesting panel on optimizing the regulatory environment at the 3rd Value Added Medicines Conference last week. Medicines for Europe

Germany leading the way...#comeonbelgium dashplus.be/blog/digital-h…

Voor jou ook en geniet van de feestdagen.

Still a lot of M&A activity in the Life Sciences market. Drug manufacturers have spent a record $342 billion on M&A in 2019 on.mktw.net/2PyQkMC

Astellas joins gene therapy race with $3B Audentes buy biopharmadive.com/news/astellas-… via BioPharma Dive

Today is the one year anniversary of Modis in Belgium. Thank you to everyone for this incredible year! Let’s make some more memories in the next year! Privileged leading Modis Belgium & working with amazing team of 500 professionals.#ConnectSmarter #oneModis #StrongerTogether

Hopeful news...Moderna delivers first human data for a coronavirus vaccine biopharmadive.com/news/moderna-c… #Covid_19 Modis Belgium

We're proud to announce that Rejuvenate Biomed has raised a €3.2 million Series A #investment round to advance the development of our #HealthyAging products, including our lead candidate under development for #sarcopenia! ow.ly/zR6Q50DNuuX